Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Glutathione S-transferase P (GSTP), also known as GST pi or GSTP1, is a member of the glutathione S-transferase (GST) superfamily. These enzymes are primarily involved in phase II detoxification processes, catalyzing the conjugation of reduced glutathione (GSH) to a wide variety of hydrophobic and electrophilic compounds, including environmental toxins, carcinogens, and products of oxidative stress. GSTP is encoded by the polymorphic human gene *GSTP1*. It plays a role in detoxification, redox homeostasis, signal transduction, and apoptosis, and is clinically relevant in cancer susceptibility and drug resistance. It is a potential drug target for overcoming drug resistance and enhancing cancer therapy.
Inhibition of GSTP activity; silencing of *GSTP1* gene expression
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Glutathione S-transferase P (GSTP).